Mepsevii Injection
Product Images NDC 69794-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mepsevii (NDC 69794-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ultragenyx Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Mepsevii 01)

A dual-panel line graph showing Six Minute Walk Test Distance (m) over treatment weeks for patients receiving placebo and MEPSEVII. The left panel tracks patients 1 to 3, and the right panel tracks patients 4 to 10, with various markers representing each patient. The graph illustrates changes in walk distance from weeks -16 to 184 under both placebo and MEPSEVII treatment.*

FDA Label Image

Principal Display Panelndc 69794-001-01mepsevii(vestronldase Alfa-vjbk)injection10 mg/ 5 mL (2mg/ml)rx Only (Mepsevii 02)

Packaging label for MEPSEVII injection 10 mg/5 mL (2 mg/mL) containing vestronidase alfa-vjbk for intravenous infusion. The label indicates it is a single-dose vial, Rx only, manufactured by Ultragenyx Pharmaceutical Inc. It lists storage instructions, inactive ingredients, and contains branding and regulatory information including NDC 69794-001-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.